Cargando…
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
Hepatocellular carcinoma (HCC) is a deadly tumour whose causative agents are generally well known, but whose pathogenesis remains poorly understood. Nevertheless, key genetic alterations are emerging from a heterogeneous molecular landscape, providing information on the tumorigenic process from init...
Autores principales: | Fernández-Barrena, Maite G., Arechederra, María, Colyn, Leticia, Berasain, Carmen, Avila, Matias A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585149/ https://www.ncbi.nlm.nih.gov/pubmed/33134907 http://dx.doi.org/10.1016/j.jhepr.2020.100167 |
Ejemplares similares
-
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020) -
Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
por: Arechederra, María, et al.
Publicado: (2021) -
SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease
por: Gárate-Rascón, María, et al.
Publicado: (2022) -
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
por: Canale, Matteo, et al.
Publicado: (2020) -
Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis
por: Barcena-Varela, Marina, et al.
Publicado: (2019)